Works matching IS 03936155 AND DT 2023 AND VI 38 AND IP 2

Results: 9

Ensuring efficient development of personalized medicine by addressing regulatory needs: What role can research infrastructures play?
Published in:
International Journal of Biological Markers, 2023, v. 38, n. 2, p. 77, doi. 10.1177/03936155231179981
By:
- Capone, Francesca;
- Morrow, David;
- Moretti, Franca
Publication type:
Article
Effect of secretory DKK3 on circulating CD56 bright natural killer cells in patients with liver cancer.
Published in:
International Journal of Biological Markers, 2023, v. 38, n. 2, p. 99, doi. 10.1177/03936155231169796
By:
- Liu, Da-Hua;
- Wen, Gui-Min;
- Song, Chang-Liang;
- Xia, Pu
Publication type:
Article
Alterations of commensal microbiota are associated with pancreatic cancer.
Published in:
International Journal of Biological Markers, 2023, v. 38, n. 2, p. 89, doi. 10.1177/03936155231166721
By:
- Chen, Tian;
- Li, Xuejiao;
- Li, Gaoming;
- Liu, Yun;
- Huang, Xiaochun;
- Ma, Wei;
- Qian, Chao;
- Guo, Jie;
- Wang, Shuo;
- Qin, Qin;
- Liu, Shanrong
Publication type:
Article
MMR markers correlate with clinical outcome in patients with esophageal squamous cell carcinoma.
Published in:
International Journal of Biological Markers, 2023, v. 38, n. 2, p. 105, doi. 10.1177/03936155231165068
By:
- Yamauchi, Takuro;
- Fujishima, Fumiyoshi;
- Tsunokake, Junichi;
- Kunimitsu, Atsushi;
- Akaishi, Ryujiro;
- Ozawa, Yohei;
- Fukutomi, Toshiaki;
- Okamoto, Hiroshi;
- Sato, Chiaki;
- Taniyama, Yusuke;
- Kamei, Takashi;
- Ichinohasama, Ryo;
- Sasano, Hironobu
Publication type:
Article
Analysis of systemic inflammatory and coagulation biomarkers in advanced cervical cancer: Prognostic and predictive significance.
Published in:
International Journal of Biological Markers, 2023, v. 38, n. 2, p. 133, doi. 10.1177/03936155231163599
By:
- Li, Ningfeng;
- Zhang, Yan;
- Qu, Wenjie;
- Zhang, Chao;
- Ding, Zhaoxia;
- Wang, Linlin;
- Cui, Baoxia
Publication type:
Article
Overexpression of complement C5a indicates poor survival and therapeutic response in metastatic renal cell carcinoma.
Published in:
International Journal of Biological Markers, 2023, v. 38, n. 2, p. 124, doi. 10.1177/03936155231161366
By:
- Yang, Changjun;
- Yang, Faying;
- Chen, Xiang;
- Li, Yunpeng;
- Hu, Xiaoyi;
- Guo, Jianming;
- Yao, Jiaxi
Publication type:
Article
Pleural CEA, CA-15-3, CYFRA 21-1, CA-19-9, CA-125 discriminating malignant from benign pleural effusions: Diagnostic cancer biomarkers.
Published in:
International Journal of Biological Markers, 2023, v. 38, n. 2, p. 81, doi. 10.1177/03936155231158661
By:
- Fazli Khalaf, Farzaneh;
- Asadi Gharabaghi, Mehrnaz;
- Balibegloo, Maryam;
- Davari, Hamidreza;
- Afshar, Samaneh;
- Jahanbin, Behnaz
Publication type:
Article
Diagnosis of malignant pleural effusion with combinations of multiple tumor markers: A comparison study of five machine learning models.
Published in:
International Journal of Biological Markers, 2023, v. 38, n. 2, p. 139, doi. 10.1177/03936155231158125
By:
- Zhang, Yixi;
- Wang, Jingyuan;
- Liang, Baosheng;
- Wu, Hanyu;
- Chen, Yangyu
Publication type:
Article
Gleason Score-related MT1L as biomarker for prognosis in prostate adenocarcinoma and contribute to tumor progression in vitro.
Published in:
International Journal of Biological Markers, 2023, v. 38, n. 2, p. 114, doi. 10.1177/03936155231156458
By:
- Liu, Lei;
- Li, Yaping;
- Tang, Shiying;
- Yang, Bin;
- Zhang, Qiming;
- Xiao, Ruotao;
- Hou, Xiaofei;
- Liu, Cheng;
- Ma, Lulin
Publication type:
Article